Novel targets of the Wilms’ tumour 1 gene (Wt1) in the epicardium during development
dc.contributor.advisor
Hastie, Nick
en
dc.contributor.author
Velecela Chuquilla, Victor Leonardo
en
dc.contributor.author
Chuquilla, Victor Leonardo
en
dc.contributor.author
Velecela, Victor Leonardo
en
dc.contributor.sponsor
Medical Research Council (MRC)
en
dc.date.accessioned
2013-11-14T15:32:26Z
dc.date.available
2013-11-14T15:32:26Z
dc.date.issued
2012-11-30
dc.description.abstract
Cardiovascular and heart diseases are the leading causes of death worldwide. In
mammals, when heart damage occurs this organ is unable to regenerate itself.
Understanding how to induce a regenerative process has been the focus of a great
deal of attention recently. The understanding of heart development and the initial
formation of several heart lineages could be used in finding a regenerative approach
to heart damage that can mimic developmental processes.
The Wilms’ tumour 1 gene (Wt1) is essential in the epicardium, the outer layer of
cells around the heart, which during development has a multipotent potential and is
the source of progenitors for several heart cell lineages such as: cells of the coronary
vasculature, fibroblasts and cardiomyocytes. In my thesis I have focused on using an
in-vitro (immortalized epicardial cells where Wt1 can be deleted by adding
tamoxifen), and an in-vivo approach (genome wide expression analyses of Wt1
control and Wt1 knock-out epicardial enriched cells), to identify novel targets of Wt1
in the epicardium during development.
I found that the chemokines Cxcl10 and Ccl5 are up-regulated in tamoxifen induced
immortalized Wt1 knock-out epicardial cells and ex-vivo in heart explants when Wt1
is down-regulated. Ccl5 was found to be able to inhibit cardiomyocyte proliferation
and Cxcl10 also inhibited epicardial cell migration, which could further explain
ventricular thinning in Wt1 mutant mouse hearts. Wt1 is able to bind directly to the
promoter of a chemokine and interferon response regulator gene, Irf7, which is also
up-regulated in our in-vivo model. This could provide a mechanism by which Wt1
can inhibit chemokine expression during development, and could link Wt1 with
immunological responses, which recently have been shown to play a role in the
physiology and development of cells outside immunity, as well as being involved in
physiological roles during damage and repair in adult tissues.
I have also identified two Wt1-GFP populations (Wt1GFP++ and Wt1GFP+) in the
ventricles of Wt1-GFP knock-in mice. The Wt1GFP++ population is enriched for
epicardial cells, and a genome wide transcriptome analysis of these cells from E11.5 to E16.5 demonstrates they have a very dynamic regulation of a wide variety of
genes, and also it indicates the existence of an early, transient and late Wt1GFP++ gene
expression programs.
The transcriptome analysis of Wt1GFP++ control and Wt1GFP++ Wt1 knock-out cells,
from Gata5-Cre Wt1loxP/gfp mice at E13.5, reveals that Wt1 could regulate a number
of previously un-described Wt1 targets related to the early Wt1GFP++ program, and
gene ontology analyses indicate that many targets are related to cell to cell signalling
and interaction, cell to extracellular matrix interaction, tissue development and
morphogenesis. The Wt1GFP+ cell population is positive for a number of
cardiomyocyte specific markers and has a low or negative expression of endothelial,
epithelial and mesenchymal markers according to my transcriptome analysis.
The findings I have described here shed light on the variety of targets of Wt1 and
further reveal the function of Wt1 during epicardial development, which could be
used in finding a regenerative approach to heart disease.
en
dc.identifier.uri
http://hdl.handle.net/1842/8139
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Martínez-Estrada OM, Lettice LA, Essafi A, Guadix JA, Slight J, Velecela V, Hall E, Reichmann J, Devenney PS, Hohenstein P, Hosen N, Hill RE, Muñoz-Chapuli R, Hastie ND.Nat Genet. 2010 Jan;42(1):89-93. Epub 2009 Dec 20.
en
dc.relation.hasversion
Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2. Guadix JA, Ruiz-Villalba A, Lettice L, Velecela V, Muñoz-Chápuli R, Hastie ND, Pérez-Pomares JM, Martínez-Estrada OM.Development. 2011 Mar;138(6):1093-7.
en
dc.relation.hasversion
A Wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression. Essafi A, Webb A, Berry RL, Slight J, Burn SF, Spraggon L, Velecela V, Martinez- Estrada OM, Wiltshire JH, Roberts SG, Brownstein D, Davies JA, Hastie ND, Hohenstein P.Dev Cell. 2011 Sep 13;21(3):559-74. Epub 2011 Aug 25.
en
dc.subject
Wilms’ tumour 1 gene
en
dc.subject
Wt1
en
dc.subject
epicardium
en
dc.title
Novel targets of the Wilms’ tumour 1 gene (Wt1) in the epicardium during development
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- Velecela Chuquilla2012.pdf
- Size:
- 6.89 MB
- Format:
- Adobe Portable Document Format
- Description:
- one year restriction
This item appears in the following Collection(s)

